Cancer Types

Common cancer types: symptoms, diagnostic methods and current treatment options.

Digestive system

Stomach Cancer: Symptoms, Diagnosis and Current Treatment Options

Sources reviewed by: Assoc. Prof. Dr. Ali OğulLast updated: October 2026

  • 4 min read
  • 6 scientific sources
  • 4 questions and answers

Stomach cancer is a type of cancer that develops from the cells lining the inner surface of the stomach, and its symptoms are often confused with digestive complaints. Drug treatments given together with surgery and new options based on tumour biomarkers have changed the treatment approach considerably.

Key information

DefinitionA malignant tumour arising from cells lining the inner surface of the stomach (mostly adenocarcinoma)
Main risksH. pylori infection, salted/smoked foods, smoking, family history
Common symptomsIndigestion, stomach pain, early satiety, weight loss, anaemia
DiagnosisEndoscopy and biopsy, CT, endoscopic ultrasound; HER2, PD-L1, MSI, Claudin 18.2
TreatmentSurgery, perioperative chemotherapy, targeted drugs, immunotherapy
Gastric cancer: 3D medical illustration showing a tumour in the stomach
Stomach cancer: 3D medical illustration. Not to scale. The image is an original illustration prepared for draliogul.com.

What is stomach cancer?

The great majority of stomach cancers are adenocarcinomas. The tumour can be located in the upper part of the stomach, near the junction with the oesophagus (cardia), or in the lower parts of the stomach; the location affects both the symptoms and the surgical approach [3].

What causes stomach cancer? Risk factors

One of the most important risk factors is infection with Helicobacter pylori, which causes long-term inflammation of the stomach lining [1]. A diet rich in salted, smoked or improperly stored foods and low in vegetables and fruit, and smoking, also increase the risk. Atrophic gastritis, a family history of stomach cancer and inherited conditions such as hereditary diffuse gastric cancer or Lynch syndrome are other risk factors [1][2].

How common is stomach cancer?

According to World Health Organization data, stomach cancer is among the most common cancers worldwide, with about 1 million new cases in 2024, and is also among the top five causes of cancer-related death [4].

What are the symptoms of stomach cancer?

  • Persistent indigestion, heartburn or pain in the stomach
  • Feeling full quickly after eating little, loss of appetite
  • Nausea, vomiting
  • Difficulty swallowing (especially in tumours of the upper stomach)
  • Unexplained weight loss, black stools, anaemia

In the early stage symptoms may be mild and non-specific; endoscopic evaluation is important for long-lasting digestive complaints [2].

How is stomach cancer diagnosed?

The diagnosis is made by biopsy taken during upper gastrointestinal endoscopy. For staging, thoracic-abdominal CT is used, and when needed endoscopic ultrasound and PET-CT; in locally advanced disease, diagnostic laparoscopy may be recommended to assess spread to the peritoneum [3].

Biomarker tests

In advanced disease, determining the status of HER2, PD-L1 (CPS), MSI/MMR and Claudin 18.2 in tumour tissue directly affects the choice of targeted drug and immunotherapy [3][5].

How is stomach cancer treated?

Treatment is planned according to the stage, the location of the tumour and the biomarker results. Assoc. Prof. Dr. Ali Oğul’s approach is to evaluate patient files in a multidisciplinary tumour board together with specialists in general surgery, gastroenterology, radiology and pathology.

Early and localised disease

Very early-stage selected tumours can be removed endoscopically. In localised disease, the standard approach is gastrectomy with lymph node dissection together with chemotherapy given before and after surgery (such as the perioperative FLOT protocol) [3][6].

Advanced disease

The mainstay of treatment is chemotherapy containing platinum and fluorouracil. In HER2-positive tumours, trastuzumab is added to chemotherapy. In HER2-negative tumours with PD-L1 expression, immunotherapy drugs such as nivolumab or pembrolizumab can be used together with chemotherapy. In Claudin 18.2-positive tumours, zolbetuximab is an option. In later lines, ramucirumab (together with paclitaxel) or, in HER2-positive disease, antibody-drug conjugates such as trastuzumab deruxtecan can be considered [3][5].

Side effects and follow-up during treatment

Chemotherapy can cause fatigue, nausea and a fall in blood counts. After stomach surgery, eating small, frequent meals, support from a dietitian and monitoring of vitamin B12 and iron levels are important. After treatment, follow-up is done with regular examination, blood tests and imaging.

Can stomach cancer be prevented?

Recognising and treating H. pylori infection, reducing salted and smoked foods, eating more vegetables and fruit and quitting smoking can lower the risk [1][2]. In people with a familial risk, endoscopic surveillance and genetic counselling may be considered.

Frequently asked questions

No. It is estimated that about two-thirds of the world’s population carry this bacterium, and the great majority of carriers do not develop stomach cancer. Even so, long-term infection is an important factor that increases the risk [1].

Over time most patients adapt to regular eating; at first, small, frequent meals and adequate protein and vitamin support are recommended.

Most cases are not hereditary; however, in people with many family members affected or with stomach cancer at a young age, genetic counselling may be recommended for syndromes such as hereditary diffuse gastric cancer [2].

The HER2, PD-L1, MSI and Claudin 18.2 results determine which targeted drug or immunotherapy may be suitable [3][5].

Call +90 530 250 54 85 or write to the same number via WhatsApp. The outpatient clinic is open Monday to Friday, 08:00–16:00.

At the medical oncology outpatient clinic of Mersin University Faculty of Medicine Oncology Hospital, Çiftlikköy Campus, 33110 Yenişehir/Mersin, Türkiye. The assessment is done in person.

When needed, yes. The multidisciplinary tumour board meets every Friday from 09:00 to 13:00, and the sequence of surgery, radiotherapy and drug treatment is planned jointly.

Yes. A second opinion is a common way to clarify a treatment plan. Bring your pathology, imaging and discharge reports to the clinic for the assessment.

Pathology report, imaging reports and, if possible, the image CDs, discharge summary, recent blood tests and a list of the medicines you take. Translated copies are helpful if your documents are not in Turkish or English.

Medical oncology consultation for gastric cancer in Mersin

If you have been diagnosed with gastric cancer, or your diagnostic work-up is ongoing, you can apply for a medical oncology consultation with Assoc. Prof. Dr. Ali Oğul at Mersin University Faculty of Medicine Oncology Hospital (Çiftlikköy Campus, 33110 Yenişehir/Mersin, Türkiye). Medical oncology covers the planning of drug treatments such as chemotherapy, targeted therapy, immunotherapy and hormone therapy, the monitoring of side effects and follow-up after treatment. The hospital has a day treatment unit where drug treatments are given.

Treatment decisions are made by a team. When needed, patient files are discussed at the multidisciplinary tumour board, which meets every Friday from 09:00 to 13:00 with specialists from the relevant departments.

For appointments, call +90 530 250 54 85 or send a WhatsApp message to the same number with your name, diagnosis and reason for the request; you can also send your reports. The outpatient clinic is open Monday to Friday, 08:00–16:00. No diagnosis or treatment recommendation is given via WhatsApp; the assessment takes place in person at the clinic. Consultations are held in Turkish.

Contact and directions · Second opinion in cancer

Appointment

Evaluation and second opinion

If you have been diagnosed with stomach cancer or would like a second opinion on your treatment plan, you can contact Assoc. Prof. Dr. Ali Oğul with your endoscopy and pathology reports, imaging results and biomarker test reports.

This content is for information only; please consult your physician for diagnosis and treatment.

References

  1. National Cancer Institute (NCI). Helicobacter pylori (H. pylori) and Cancer. Reviewed: 12.04.2023. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/h-pylori-fact-sheet
  2. National Cancer Institute (NCI). Causes of Stomach Cancer. Updated: 08.05.2025. https://www.cancer.gov/types/stomach/causes-risk-factors
  3. Lordick F, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005-1020. DOI: 10.1016/j.annonc.2022.07.004
  4. World Health Organization (WHO). Cancer – Fact sheet. Accessed: October 2026 (2024 data). https://www.who.int/news-room/fact-sheets/detail/cancer
  5. American Cancer Society (ACS). Targeted Therapy Drugs for Stomach Cancer. Last revised: 28.08.2026. https://www.cancer.org/cancer/types/stomach-cancer/treating/targeted-therapies.html
  6. Al-Batran SE, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4). Lancet. 2019;393(10184):1948-1957. DOI: 10.1016/S0140-6736(18)32557-1

Links open external sources. The references were accessible as of October 2026.